About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Docs on Twitter


Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Sanofi-Synthelabo v. Apotex Inc. (S.D.N.Y. 2007) | Main | The Effect of Foreign Generics on the U.S. Drug Supply - Part II »

June 20, 2007

EPO Filings up in 2006

    By Donald Zuhn --

Epoepc On Monday, the European Patent Office (EPO) announced that patent filings rose by 5% in 2006, jumping from 197,400 in 2005 to 207,300 in 2006.  While the proportion of filings originating from the 32 EPO member states fell from 49.6% to 48.5%, the number of filings originating from the U.S. rose slightly from 16.6% to 16.8%.

The EPO also announced that patent grants went up 17.9% in 2006, rising from 53,255 in 2005 to 62,780 in 2006.  U.S. applicants collected 14,834 European patents in 2006.

Of the top 100 filers in 2006, Bayer topped the list of biotech and pharma companies, finishing 14th overall with 604 filed applications.  With respect to subject matter, 2006 filings in the area of medical technology were up 6.8%, filings related to organic chemistry and macromolecular compounds were up 10.6%, and biotechnology filings were down 5.3%.

For more information concerning this topic, please see the EPO's Annual Report for 2006.

Posted at 10:46 PM in Patent Prosecution - International |

Comments

The comments to this entry are closed.

March 2023

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Categories

Archives

More...